Hepatocellular carcinoma: Review of the literature
1 Department of Internal Medicine Sunrise Health GME Consortium 2880 N Tenaya Way 2nd Floor Las Vegas, NV, USA ***.
2 Faculty Attending, Department of Internal Medicine Sunrise Health GME Consortium Las Vegas, NV, USA.
Review Article
GSC Advanced Research and Reviews, 2022, 10(03), 122–130.
Article DOI: 10.30574/gscarr.2022.10.3.0066
Publication history:
Received on 28 January 2022; revised on 11 March 2022; accepted on 13 March 2022
Abstract:
Hepatocellular carcinoma is the most common primary liver malignancy. Risk factors as viral infection, obesity, excessive alcohol use, and tobacco use are associated with the development of hepatocellular carcinoma. Hepatocellular carcinoma presentation ranges from asymptomatic to upper abdominal pain along with lethargy, weight loss, nausea, and anorexia. Different staging systems has developed in the past to stage hepatocellular carcinoma. Many treatment approaches have been used for HCC including chemotherapy, immunotherapy, ablation therapy, surgery, and liver transplantation.
Keywords:
Hepatocellular carcinoma; Risk factors; Staging; Prevention; Treatment
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
